The African Medicines Agency : Vision and Strategy for the African Continent
In collaboration with the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and its sister Association, the French Association of Pharmaceutical Companies (LEEM) we are jointly organizing a roundtable on the African Medicines Agency: Vision and Strategy for the African Continent on 22 June 2021 from 15h to 17h CET.
The African Medicines Agency (AMA) creates an unprecedented opportunity for improved regulatory reliance and strengthening resulting in speeder access to medicines and vaccines for people throughout the continent. Moreover, it represents, for many countries, the promise of the development of local production, and the development, across the continent,of centers of excellence for research, the strengthening and security of supply chains, for the maintenance of a healthy environment and the fight against falsified medicines.
The Agency’s functions are clearly defined, but a common vision and strategy remain to be built and more member states need to sign and ratify the treaty establishing the African Medicines Agency to make it operational.
In this framework, and at the initiative of the African Union Special Envoy for AMA, Mr Michel Sidibé, the International Alliance of Patient Organizations (IAPO), the International Federation of Pharmaceutical Associations and Manufacturers (IFPMA) and the French Pharmaceutical Companies Association (LEEM) are co-organizing a high-level roundtable on 22 June, with Ministers of Health of African countries, and representatives from various stakeholders, namely international organizations, patient associations the pharmaceutical industry and the European Medicines Agency.
When: 22 June, 2021 15:00 -17:00 CEST (Paris)
Where: Virtual event
Interpretation: English, French, Portuguese available